Biomet, Inc. Announces Fiscal Year 2013 Fourth Quarter and Year End Conference Call

WARSAW, Ind.--()--Biomet, Inc. announced today that in conjunction with its Fiscal 2013 Fourth Quarter and Year End release, you are invited to participate in the conference call on Thursday, July 11, 2013 at 4:30 p.m. Eastern.

Individuals wishing to participate in the conference call may dial (877) 606-1415. International callers should dial (760) 666-3758. The conference ID number is 10622937.

Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses large joint reconstructive products, including orthopedic joint replacement devices, and bone cements and accessories; sports medicine, extremities and trauma products, including internal and external orthopedic fixation devices; spine and bone healing products, including spine hardware, spinal stimulation devices, and orthobiologics, as well as electrical bone growth stimulators; dental reconstructive products; and other products, including microfixation products and autologous therapies. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.

Contacts

Biomet, Inc.
Carolyn Beatty, Investor Relations, 574-372-1571
or
Barbara Goslee, Corporate Communications, 574-372-1514

Contacts

Biomet, Inc.
Carolyn Beatty, Investor Relations, 574-372-1571
or
Barbara Goslee, Corporate Communications, 574-372-1514